CompletedNot Applicable

Development of a Scale for Evaluation of Neuromotor Development of Infants

Turkey (Türkiye)68 participantsStarted 2022-03-16

Plain-language summary

Although the scales used so far provide information about the neuromotor progression of a single baby, it is thought that they are not sufficient to distinguish babies from each other, and it is thought that there is no assessment battery that will adapt to the knowledge in their conditions and the functional development of babies. Therefore, the aim of our study is to reveal the applicability and psychometric properties of the Neonatal Infant Motor Assessment Scale (NIMAS) test, which reveals the neurological and motor performance of infants hospitalized in the NICU, both as automatic responses and functional behavior.

Who can participate

Age range1 Day – 1 Month

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Born between 24-42 weeks of gestational age, * The baby's vital signs are stable on the day of the test. Exclusion Criteria: * To undergo surgery, * to be in the early post-op period \<7 days (the day of the tests), * Receiving treatment for sepsis or intensive phototherapy, * The baby is intubated and on a mechanical ventilator, * Unstable vital signs and taking sedative drugs, * Having a genetic syndrome, * Having other medical conditions that may affect physiotherapy practice, such as multiple congenital anomalies, tracheoesophageal fistula, diaphragmatic hernia, congenital heart malformation, and/or necrotizing enterocolitis.

What they're measuring

Neonatal Infant Motor Assessment Scale

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05860166

SponsorOndokuz Mayıs University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-01

View on ClinicalTrials.gov More Infant Development trials